Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022

Loading...
Loading...

Upgrades

Wolfe Research upgraded the previous rating for EQT Corp EQT from Peer Perform to Outperform. EQT earned $1.04 in the third quarter, compared to $0.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.97 and a 52-week-low of $19.20. EQT closed at $37.11 at the end of the last trading period.

For Lennar Corp LEN, Barclays upgraded the previous rating of Equal-Weight to Overweight. At the moment, the stock has a 52-week-high of $117.54 and a 52-week-low of $62.54. Lennar closed at $90.59 at the end of the last trading period.

According to Barclays, the prior rating for PulteGroup Inc PHM was changed from Equal-Weight to Overweight. For the third quarter, PulteGroup had an EPS of $2.69, compared to year-ago quarter EPS of $1.82. The stock has a 52-week-high of $58.09 and a 52-week-low of $35.03. At the end of the last trading period, PulteGroup closed at $45.79.

For SolarEdge Technologies Inc SEDG, Barclays upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, SolarEdge Technologies showed an EPS of $0.91, compared to $1.45 from the year-ago quarter. The stock has a 52-week-high of $375.90 and a 52-week-low of $190.15. At the end of the last trading period, SolarEdge Technologies closed at $327.64.

For RingCentral Inc RNG, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, RingCentral showed an EPS of $0.55, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $198.79 and a 52-week-low of $28.00. RingCentral closed at $38.95 at the end of the last trading period.

Morgan Stanley upgraded the previous rating for PACCAR Inc PCAR from Equal-Weight to Overweight. In the third quarter, PACCAR showed an EPS of $2.21, compared to $1.08 from the year-ago quarter. The current stock performance of PACCAR shows a 52-week-high of $107.18 and a 52-week-low of $77.00. Moreover, at the end of the last trading period, the closing price was at $102.22.

For Datadog Inc DDOG, Oppenheimer upgraded the previous rating of Perform to Outperform. For the third quarter, Datadog had an EPS of $0.23, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $186.28 and a 52-week-low of $66.45. Datadog closed at $79.71 at the end of the last trading period.

Wells Fargo upgraded the previous rating for Fortis Inc FTS from Underweight to Equal-Weight. For the third quarter, Fortis had an EPS of $0.54, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $51.66 and a 52-week-low of $34.76. At the end of the last trading period, Fortis closed at $40.99.

For Playa Hotels & Resorts NV PLYA, Citigroup upgraded the previous rating of Neutral to Buy. In the third quarter, Playa Hotels & Resorts showed an EPS of $0.04, compared to $0.09 from the year-ago quarter. The current stock performance of Playa Hotels & Resorts shows a 52-week-high of $9.81 and a 52-week-low of $5.34. Moreover, at the end of the last trading period, the closing price was at $6.12.

According to Wedbush, the prior rating for Darden Restaurants Inc DRI was changed from Neutral to Outperform. In the first quarter, Darden Restaurants showed an EPS of $1.56, compared to $1.76 from the year-ago quarter. The current stock performance of Darden Restaurants shows a 52-week-high of $155.25 and a 52-week-low of $110.96. Moreover, at the end of the last trading period, the closing price was at $145.03.

For Gentex Corp GNTX, Goldman Sachs upgraded the previous rating of Sell to Neutral. Gentex earned $0.31 in the third quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $36.65 and a 52-week-low of $23.28. At the end of the last trading period, Gentex closed at $27.43.

For Ncino Inc NCNO, Baird upgraded the previous rating of Neutral to Outperform. For the third quarter, Ncino had an EPS of $0.01, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $58.71 and a 52-week-low of $22.97. At the end of the last trading period, Ncino closed at $26.67.

Baird upgraded the previous rating for Ansys Inc ANSS from Neutral to Outperform. Ansys earned $1.77 in the third quarter, compared to $1.59 in the year-ago quarter. At the moment, the stock has a 52-week-high of $413.22 and a 52-week-low of $194.23. Ansys closed at $254.54 at the end of the last trading period.

Keybanc upgraded the previous rating for EastGroup Properties Inc EGP from Sector Weight to Overweight. In the third quarter, EastGroup Props showed an EPS of $1.77, compared to $1.55 from the year-ago quarter. At the moment, the stock has a 52-week-high of $229.84 and a 52-week-low of $137.47. EastGroup Props closed at $156.84 at the end of the last trading period.

Keybanc upgraded the previous rating for Physicians Realty Trust DOC from Sector Weight to Overweight. In the third quarter, Physicians Realty Trust showed an EPS of $0.26, compared to $0.26 from the year-ago quarter. The current stock performance of Physicians Realty Trust shows a 52-week-high of $19.12 and a 52-week-low of $13.42. Moreover, at the end of the last trading period, the closing price was at $15.00.

See all analyst ratings upgrades.

Downgrades

According to Chardan Capital, the prior rating for Moderna Inc MRNA was changed from Buy to Neutral. For the third quarter, Moderna had an EPS of $2.53, compared to year-ago quarter EPS of $7.70. The current stock performance of Moderna shows a 52-week-high of $321.31 and a 52-week-low of $115.03. Moreover, at the end of the last trading period, the closing price was at $197.54.

According to Citigroup, the prior rating for Grupo Aeroportuario del Centro Norte SAB de CV OMAB was changed from Neutral to Sell. In the third quarter, Central North Airport Gr showed an EPS of $1.13, compared to $0.81 from the year-ago quarter. The current stock performance of Central North Airport Gr shows a 52-week-high of $71.86 and a 52-week-low of $46.53. Moreover, at the end of the last trading period, the closing price was at $66.26.

B of A Securities downgraded the previous rating for PENN Entertainment Inc PENN from Buy to Neutral. In the third quarter, PENN Entertainment showed an EPS of $0.72, compared to $0.52 from the year-ago quarter. The stock has a 52-week-high of $53.36 and a 52-week-low of $25.49. At the end of the last trading period, PENN Entertainment closed at $35.04.

For Stock Yards Bancorp Inc SYBT, Piper Sandler downgraded the previous rating of Neutral to Underweight. Stock Yards Bancorp earned $0.89 in the third quarter, compared to $0.87 in the year-ago quarter. The current stock performance of Stock Yards Bancorp shows a 52-week-high of $78.71 and a 52-week-low of $50.83. Moreover, at the end of the last trading period, the closing price was at $72.22.

Barclays downgraded the previous rating for Skyline Champion Corp SKY from Overweight to Equal-Weight. In the second quarter, Skyline Champion showed an EPS of $2.51, compared to $0.89 from the year-ago quarter. The current stock performance of Skyline Champion shows a 52-week-high of $83.49 and a 52-week-low of $43.04. Moreover, at the end of the last trading period, the closing price was at $55.72.

Citigroup downgraded the previous rating for SL Green Realty Corp SLG from Neutral to Sell. For the third quarter, SL Green Realty had an EPS of $1.66, compared to year-ago quarter EPS of $1.78. At the moment, the stock has a 52-week-high of $83.96 and a 52-week-low of $34.21. SL Green Realty closed at $36.35 at the end of the last trading period.

For Coupa Software Inc COUP, Citigroup downgraded the previous rating of Buy to Neutral. For the third quarter, Coupa Software had an EPS of $0.15, compared to year-ago quarter EPS of $0.31. The current stock performance of Coupa Software shows a 52-week-high of $166.21 and a 52-week-low of $40.30. Moreover, at the end of the last trading period, the closing price was at $78.60.

For Caesars Entertainment Inc CZR, B of A Securities downgraded the previous rating of Buy to Neutral. In the third quarter, Caesars Entertainment showed an EPS of $0.24, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $97.39 and a 52-week-low of $31.31. At the end of the last trading period, Caesars Entertainment closed at $52.55.

For Best Buy Co Inc BBY, B of A Securities downgraded the previous rating of Neutral to Underperform. Best Buy Co earned $1.38 in the third quarter, compared to $2.08 in the year-ago quarter. The current stock performance of Best Buy Co shows a 52-week-high of $112.96 and a 52-week-low of $60.78. Moreover, at the end of the last trading period, the closing price was at $84.07.

B of A Securities downgraded the previous rating for AutoZone Inc AZO from Neutral to Underperform. In the first quarter, AutoZone showed an EPS of $27.45, compared to $25.69 from the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of $2610.05 and a 52-week-low of $1703.32. Moreover, at the end of the last trading period, the closing price was at $2393.46.

According to Daiwa Capital, the prior rating for XPeng Inc XPEV was changed from Buy to Sell. XPeng earned $0.36 in the third quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.50 and a 52-week-low of $6.18. XPeng closed at $10.31 at the end of the last trading period.

For Centerspace CSR, Janney Montgomery Scott downgraded the previous rating of Buy to Neutral. In the third quarter, Centerspace showed an EPS of $1.15, compared to $0.98 from the year-ago quarter. At the moment, the stock has a 52-week-high of $112.27 and a 52-week-low of $60.52. Centerspace closed at $66.15 at the end of the last trading period.

Janney Montgomery Scott downgraded the previous rating for Essex Property Trust Inc ESS from Buy to Neutral. In the third quarter, Essex Property Trust showed an EPS of $3.69, compared to $3.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $363.36 and a 52-week-low of $205.76. Essex Property Trust closed at $223.21 at the end of the last trading period.

According to Truist Securities, the prior rating for Harpoon Therapeutics Inc HARP was changed from Buy to Hold. In the third quarter, Harpoon Therapeutics showed an EPS of $0.35, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $8.20 and a 52-week-low of $0.66. At the end of the last trading period, Harpoon Therapeutics closed at $0.89.

For Vornado Realty Trust VNO, Citigroup downgraded the previous rating of Neutral to Sell. Vornado Realty earned $0.81 in the third quarter, compared to $0.71 in the year-ago quarter. The stock has a 52-week-high of $47.26 and a 52-week-low of $20.03. At the end of the last trading period, Vornado Realty closed at $23.06.

According to Citigroup, the prior rating for Acadia Realty Trust AKR was changed from Buy to Neutral. Acadia Realty Trust earned $0.28 in the third quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $22.64 and a 52-week-low of $12.28. Acadia Realty Trust closed at $14.98 at the end of the last trading period.

For Latham Group Inc SWIM, Barclays downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, Latham Group showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $27.25 and a 52-week-low of $2.75. At the end of the last trading period, Latham Group closed at $3.16.

Morgan Stanley downgraded the previous rating for Martin Marietta Materials Inc MLM from Overweight to Equal-Weight. For the third quarter, Martin Marietta Materials had an EPS of $4.69, compared to year-ago quarter EPS of $4.25. The stock has a 52-week-high of $446.46 and a 52-week-low of $284.99. At the end of the last trading period, Martin Marietta Materials closed at $368.73.

For Adecoagro SA AGRO, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Adecoagro earned $0.43 in the third quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Adecoagro shows a 52-week-high of $13.55 and a 52-week-low of $6.78. Moreover, at the end of the last trading period, the closing price was at $7.62.

For Syneos Health Inc SYNH, Mizuho downgraded the previous rating of Buy to Neutral. In the third quarter, Syneos Health showed an EPS of $1.23, compared to $1.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $104.17 and a 52-week-low of $22.89. Syneos Health closed at $35.50 at the end of the last trading period.

Wells Fargo downgraded the previous rating for Digital Realty Trust Inc DLR from Overweight to Equal-Weight. Digital Realty Trust earned $1.67 in the third quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Digital Realty Trust shows a 52-week-high of $178.22 and a 52-week-low of $85.76. Moreover, at the end of the last trading period, the closing price was at $111.09.

According to Wells Fargo, the prior rating for Lear Corp LEA was changed from Overweight to Equal-Weight. Lear earned $2.33 in the third quarter, compared to $0.53 in the year-ago quarter. The current stock performance of Lear shows a 52-week-high of $195.43 and a 52-week-low of $114.67. Moreover, at the end of the last trading period, the closing price was at $132.19.

For Magna International Inc MGA, Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. Magna International earned $1.07 in the third quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $90.15 and a 52-week-low of $45.58. Magna International closed at $59.87 at the end of the last trading period.

Citigroup downgraded the previous rating for Marriott International Inc MAR from Buy to Neutral. For the third quarter, Marriott Intl had an EPS of $1.69, compared to year-ago quarter EPS of $0.99. At the moment, the stock has a 52-week-high of $195.90 and a 52-week-low of $131.01. Marriott Intl closed at $163.12 at the end of the last trading period.

According to Citigroup, the prior rating for Healthcare Realty Trust Inc HR was changed from Buy to Neutral. In the third quarter, Healthcare Realty Trust showed an EPS of $0.39, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $32.38 and a 52-week-low of $18.40. At the end of the last trading period, Healthcare Realty Trust closed at $19.74.

For Hilton Worldwide Holdings Inc HLT, Citigroup downgraded the previous rating of Buy to Neutral. For the third quarter, Hilton Worldwide Holdings had an EPS of $1.31, compared to year-ago quarter EPS of $0.78. The stock has a 52-week-high of $167.99 and a 52-week-low of $108.41. At the end of the last trading period, Hilton Worldwide Holdings closed at $138.11.

For Easterly Government Properties Inc DEA, Citigroup downgraded the previous rating of Buy to Neutral. Easterly Government Props earned $0.32 in the third quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $23.65 and a 52-week-low of $14.79. At the end of the last trading period, Easterly Government Props closed at $15.04.

For Brandywine Realty Trust BDN, Citigroup downgraded the previous rating of Neutral to Sell. Brandywine Realty Trust earned $0.36 in the third quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.88 and a 52-week-low of $5.95. Brandywine Realty Trust closed at $6.52 at the end of the last trading period.

For Argo Blockchain PLC ARBK, HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the second quarter, Argo Blockchain showed an EPS of $0.82, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $14.80 and a 52-week-low of $0.36. At the end of the last trading period, Argo Blockchain closed at $0.43.

Goldman Sachs downgraded the previous rating for QuantumScape Corp QS from Neutral to Sell. For the third quarter, QuantumScape had an EPS of $0.27, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $25.10 and a 52-week-low of $6.61. At the end of the last trading period, QuantumScape closed at $7.09.

According to Baird, the prior rating for SPS Commerce Inc SPSC was changed from Outperform to Neutral. For the third quarter, SPS Commerce had an EPS of $0.63, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $146.81 and a 52-week-low of $96.41. SPS Commerce closed at $137.97 at the end of the last trading period.

For Certara Inc CERT, Baird downgraded the previous rating of Outperform to Neutral. Certara earned $0.10 in the third quarter, compared to $0.07 in the year-ago quarter. The stock has a 52-week-high of $29.99 and a 52-week-low of $10.60. At the end of the last trading period, Certara closed at $17.40.

Jefferies downgraded the previous rating for Armstrong World Industries Inc AWI from Buy to Hold. In the third quarter, Armstrong World Indus showed an EPS of $1.36, compared to $1.17 from the year-ago quarter. The stock has a 52-week-high of $117.64 and a 52-week-low of $70.50. At the end of the last trading period, Armstrong World Indus closed at $73.37.

According to RBC Capital, the prior rating for Healthpeak Properties Inc PEAK was changed from Outperform to Sector Perform. Healthpeak Properties earned $0.43 in the third quarter, compared to $0.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $36.85 and a 52-week-low of $21.41. Healthpeak Properties closed at $25.63 at the end of the last trading period.

According to Keybanc, the prior rating for VICI Properties Inc VICI was changed from Overweight to Sector Weight. For the third quarter, VICI Properties had an EPS of $0.49, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $35.69 and a 52-week-low of $26.23. VICI Properties closed at $34.39 at the end of the last trading period.

Keybanc downgraded the previous rating for Netstreit Corp NTST from Overweight to Sector Weight. For the third quarter, Netstreit had an EPS of $0.30, compared to year-ago quarter EPS of $0.22. The stock has a 52-week-high of $23.86 and a 52-week-low of $17.07. At the end of the last trading period, Netstreit closed at $19.28.

According to Keybanc, the prior rating for LTC Properties Inc LTC was changed from Overweight to Sector Weight. LTC Properties earned $0.60 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $45.49 and a 52-week-low of $32.23. At the end of the last trading period, LTC Properties closed at $38.72.

According to Keybanc, the prior rating for Essex Property Trust Inc ESS was changed from Overweight to Sector Weight. In the third quarter, Essex Property Trust showed an EPS of $3.69, compared to $3.12 from the year-ago quarter. The current stock performance of Essex Property Trust shows a 52-week-high of $363.36 and a 52-week-low of $205.76. Moreover, at the end of the last trading period, the closing price was at $223.21.

For Coupa Software Inc COUP, Keybanc downgraded the previous rating of Overweight to Sector Weight. For the third quarter, Coupa Software had an EPS of $0.15, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of $166.21 and a 52-week-low of $40.30. Coupa Software closed at $78.60 at the end of the last trading period.

According to Keybanc, the prior rating for Acadia Realty Trust AKR was changed from Overweight to Sector Weight. Acadia Realty Trust earned $0.28 in the third quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $22.64 and a 52-week-low of $12.28. At the end of the last trading period, Acadia Realty Trust closed at $14.98.

Loading...
Loading...

See all analyst ratings downgrades.

Initiations

UBS initiated coverage on Calumet Specialty Products Partners LP CLMT with a Neutral rating. The price target for Calumet Specialty is set to $15.70. In the third quarter, Calumet Specialty showed an EPS of $0.19, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $20.50 and a 52-week-low of $8.40. At the end of the last trading period, Calumet Specialty closed at $14.02.

UBS initiated coverage on Darling Ingredients Inc DAR with a Buy rating. The price target for Darling Ingredients is set to $91.00. For the third quarter, Darling Ingredients had an EPS of $1.17, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $87.59 and a 52-week-low of $55.71. At the end of the last trading period, Darling Ingredients closed at $60.87.

Cowen & Co. initiated coverage on The Simply Good Foods Co SMPL with a Market Perform rating. The price target for Simply Good Foods is set to $42.00. In the fourth quarter, Simply Good Foods showed an EPS of $0.36, compared to $0.29 from the year-ago quarter. The stock has a 52-week-high of $45.77 and a 52-week-low of $29.21. At the end of the last trading period, Simply Good Foods closed at $37.79.

Deutsche Bank initiated coverage on Maravai LifeSciences Holdings Inc MRVI with a Buy rating. The price target for Maravai LifeSciences is set to $25.00. Maravai LifeSciences earned $0.37 in the third quarter, compared to $0.44 in the year-ago quarter. The current stock performance of Maravai LifeSciences shows a 52-week-high of $43.50 and a 52-week-low of $12.16. Moreover, at the end of the last trading period, the closing price was at $14.27.

For Abcam PLC ABCM, Deutsche Bank initiated coverage, by setting the current rating at Hold. NoneAt the moment, the stock has a 52-week-high of $24.00 and a 52-week-low of $12.54. Abcam closed at $15.82 at the end of the last trading period.

With a Buy rating, Canaccord Genuity initiated coverage on Olink Holding AB OLK. The price target seems to have been set at $28.00 for Olink Holding. In the third quarter, Olink Holding showed an EPS of $0.01, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $24.93 and a 52-week-low of $8.39. At the end of the last trading period, Olink Holding closed at $23.17.

With an Outperform rating, Raymond James initiated coverage on POINT Biopharma Global Inc PNT. The price target seems to have been set at $10.00 for POINT Biopharma Global. In the third quarter, POINT Biopharma Global showed an EPS of $0.26, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of $10.98 and a 52-week-low of $4.25. At the end of the last trading period, POINT Biopharma Global closed at $6.61.

With a Buy rating, Needham initiated coverage on Revolution Medicines Inc RVMD. The price target seems to have been set at $31.00 for Revolution Medicines. In the third quarter, Revolution Medicines showed an EPS of $0.87, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $28.11 and a 52-week-low of $14.08. At the end of the last trading period, Revolution Medicines closed at $23.30.

Cowen & Co. initiated coverage on BellRing Brands Inc BRBR with an Outperform rating. The price target for BellRing Brands is set to $31.00. In the fourth quarter, BellRing Brands showed an EPS of $0.31, compared to $0.25 from the year-ago quarter. The current stock performance of BellRing Brands shows a 52-week-high of $28.95 and a 52-week-low of $20.20. Moreover, at the end of the last trading period, the closing price was at $25.12.

Cowen & Co. initiated coverage on OneSpaWorld Holdings Ltd OSW with an Outperform rating. The price target for OneSpaWorld Holdings is set to $13.00. In the third quarter, OneSpaWorld Holdings showed an EPS of $0.13, compared to $0.11 from the year-ago quarter. The current stock performance of OneSpaWorld Holdings shows a 52-week-high of $10.99 and a 52-week-low of $6.80. Moreover, at the end of the last trading period, the closing price was at $10.30.

Morgan Stanley initiated coverage on Broadridge Financial Solutions Inc BR with a Equal-Weight rating. The price target for Broadridge Financial Soln is set to $160.00. In the first quarter, Broadridge Financial Soln showed an EPS of $0.84, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $185.40 and a 52-week-low of $131.35. Broadridge Financial Soln closed at $145.20 at the end of the last trading period.

With a Buy rating, Needham initiated coverage on Day One Biopharmaceuticals Inc DAWN. The price target seems to have been set at $40.00 for Day One Biopharmaceutical. Day One Biopharmaceutical earned $0.53 in the third quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $28.35 and a 52-week-low of $5.44. At the end of the last trading period, Day One Biopharmaceutical closed at $20.10.

Needham initiated coverage on Theseus Pharmaceuticals Inc THRX with a Buy rating. The price target for Theseus Pharmaceuticals is set to $22.00. In the third quarter, Theseus Pharmaceuticals showed an EPS of $0.38, compared to $5.16 from the year-ago quarter. The current stock performance of Theseus Pharmaceuticals shows a 52-week-high of $15.21 and a 52-week-low of $4.01. Moreover, at the end of the last trading period, the closing price was at $5.50.

Needham initiated coverage on Cogent Biosciences Inc COGT with a Buy rating. The price target for Cogent Biosciences is set to $24.00. In the third quarter, Cogent Biosciences showed an EPS of $0.50, compared to $0.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.07 and a 52-week-low of $3.79. Cogent Biosciences closed at $11.95 at the end of the last trading period.

Stifel initiated coverage on Aclaris Therapeutics Inc ACRS with a Buy rating. The price target for Aclaris Therapeutics is set to $29.00. For the third quarter, Aclaris Therapeutics had an EPS of $0.30, compared to year-ago quarter EPS of $0.35. The stock has a 52-week-high of $18.96 and a 52-week-low of $9.26. At the end of the last trading period, Aclaris Therapeutics closed at $15.94.

CLSA initiated coverage on Zhihu Inc ZH with an Outperform rating. The price target for Zhihu is set to $1.50. For the third quarter, Zhihu had an EPS of $0.06, compared to year-ago quarter EPS of $0.07. The current stock performance of Zhihu shows a 52-week-high of $6.38 and a 52-week-low of $0.89. Moreover, at the end of the last trading period, the closing price was at $1.29.

Goldman Sachs initiated coverage on PTC Therapeutics Inc PTCT with a Sell rating. The price target for PTC Therapeutics is set to $35.00. In the third quarter, PTC Therapeutics showed an EPS of $1.53, compared to $1.89 from the year-ago quarter. The stock has a 52-week-high of $55.58 and a 52-week-low of $25.01. At the end of the last trading period, PTC Therapeutics closed at $40.14.

Goldman Sachs initiated coverage on Xenon Pharmaceuticals Inc XENE with a Buy rating. The price target for Xenon Pharmaceuticals is set to $60.00. For the third quarter, Xenon Pharmaceuticals had an EPS of $0.57, compared to year-ago quarter EPS of $0.36. At the moment, the stock has a 52-week-high of $41.39 and a 52-week-low of $24.36. Xenon Pharmaceuticals closed at $38.07 at the end of the last trading period.

With a Neutral rating, Citigroup initiated coverage on Solid Power Inc SLDP. The price target seems to have been set at $3.00 for Solid Power. In the third quarter, Solid Power showed an EPS of $0.07, compared to $0.08 from the year-ago quarter. The current stock performance of Solid Power shows a 52-week-high of $11.61 and a 52-week-low of $2.52. Moreover, at the end of the last trading period, the closing price was at $2.55.

For RPM International Inc RPM, Keybanc initiated coverage, by setting the current rating at Sector Weight. RPM International earned $1.47 in the first quarter, compared to $1.08 in the year-ago quarter. The stock has a 52-week-high of $106.50 and a 52-week-low of $74.56. At the end of the last trading period, RPM International closed at $104.20.

With a Buy rating, Needham initiated coverage on Blueprint Medicines Corp BPMC. The price target seems to have been set at $60.00 for Blueprint Medicines. Blueprint Medicines earned $2.23 in the third quarter, compared to $2.00 in the year-ago quarter. The current stock performance of Blueprint Medicines shows a 52-week-high of $111.78 and a 52-week-low of $40.78. Moreover, at the end of the last trading period, the closing price was at $46.60.

For Mirati Therapeutics Inc MRTX, Needham initiated coverage, by setting the current rating at Hold. Mirati Therapeutics earned $3.09 in the third quarter, compared to $1.55 in the year-ago quarter. The current stock performance of Mirati Therapeutics shows a 52-week-high of $154.17 and a 52-week-low of $32.96. Moreover, at the end of the last trading period, the closing price was at $41.97.

Canaccord Genuity initiated coverage on Pagaya Technologies Ltd PGY with a Hold rating. The price target for Pagaya Technologies is set to $1.50. The stock has a 52-week-high of $34.50 and a 52-week-low of $0.63. At the end of the last trading period, Pagaya Technologies closed at $0.69.

With a Buy rating, BTIG initiated coverage on CompoSecure Inc CMPO. The price target seems to have been set at $9.00 for CompoSecure. At the moment, the stock has a 52-week-high of $10.69 and a 52-week-low of $4.26. CompoSecure closed at $4.86 at the end of the last trading period.

Deutsche Bank initiated coverage on Avantor Inc AVTR with a Hold rating. The price target for Avantor is set to $24.00. Avantor earned $0.34 in the third quarter, compared to $0.35 in the year-ago quarter. The stock has a 52-week-high of $42.48 and a 52-week-low of $17.91. At the end of the last trading period, Avantor closed at $22.00.

Deutsche Bank initiated coverage on Danaher Corp DHR with a Buy rating. The price target for Danaher is set to $310.00. For the third quarter, Danaher had an EPS of $2.56, compared to year-ago quarter EPS of $2.39. The current stock performance of Danaher shows a 52-week-high of $331.23 and a 52-week-low of $233.71. Moreover, at the end of the last trading period, the closing price was at $276.68.

Deutsche Bank initiated coverage on Repligen Corp RGEN with a Hold rating. The price target for Repligen is set to $180.00. In the third quarter, Repligen showed an EPS of $0.77, compared to $0.78 from the year-ago quarter. At the moment, the stock has a 52-week-high of $274.09 and a 52-week-low of $137.21. Repligen closed at $177.99 at the end of the last trading period.

With a Buy rating, Deutsche Bank initiated coverage on Bio-Techne Corp TECH. The price target seems to have been set at $100.00 for Bio-Techne. Bio-Techne earned $0.45 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $130.74 and a 52-week-low of $68.00. At the end of the last trading period, Bio-Techne closed at $86.98.

With a Buy rating, Deutsche Bank initiated coverage on Thermo Fisher Scientific Inc TMO. The price target seems to have been set at $620.00 for Thermo Fisher Scientific. In the third quarter, Thermo Fisher Scientific showed an EPS of $5.08, compared to $5.77 from the year-ago quarter. The stock has a 52-week-high of $672.34 and a 52-week-low of $475.77. At the end of the last trading period, Thermo Fisher Scientific closed at $571.38.

Deutsche Bank initiated coverage on 10x Genomics Inc TXG with a Buy rating. The price target for 10x Genomics is set to $50.00. 10x Genomics earned $0.37 in the third quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $154.10 and a 52-week-low of $23.81. 10x Genomics closed at $35.21 at the end of the last trading period.

With a Hold rating, Deutsche Bank initiated coverage on Waters Corp WAT. The price target seems to have been set at $350.00 for Waters. Waters earned $2.64 in the third quarter, compared to $2.66 in the year-ago quarter. At the moment, the stock has a 52-week-high of $375.24 and a 52-week-low of $265.61. Waters closed at $344.62 at the end of the last trading period.

Deutsche Bank initiated coverage on West Pharmaceutical Services Inc WST with a Hold rating. The price target for West Pharmaceutical Servs is set to $250.00. West Pharmaceutical Servs earned $2.03 in the third quarter, compared to $2.06 in the year-ago quarter. The stock has a 52-week-high of $475.00 and a 52-week-low of $206.19. At the end of the last trading period, West Pharmaceutical Servs closed at $251.90.

Stifel initiated coverage on Pliant Therapeutics Inc PLRX with a Buy rating. The price target for Pliant Therapeutics is set to $33.00. For the third quarter, Pliant Therapeutics had an EPS of $0.65, compared to year-ago quarter EPS of $0.75. The stock has a 52-week-high of $26.25 and a 52-week-low of $3.96. At the end of the last trading period, Pliant Therapeutics closed at $19.06.

Stifel initiated coverage on Travere Therapeutics Inc TVTX with a Hold rating. The price target for Travere Therapeutics is set to $22.00. For the third quarter, Travere Therapeutics had an EPS of $0.76, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $31.65 and a 52-week-low of $18.39. Travere Therapeutics closed at $18.93 at the end of the last trading period.

With a Buy rating, UBS initiated coverage on Clean Energy Fuels Corp CLNE. The price target seems to have been set at $12.00 for Clean Energy Fuels. For the third quarter, Clean Energy Fuels had an EPS of $0.06, compared to year-ago quarter EPS of $0.01. The current stock performance of Clean Energy Fuels shows a 52-week-high of $8.65 and a 52-week-low of $4.02. Moreover, at the end of the last trading period, the closing price was at $5.79.

With a Buy rating, UBS initiated coverage on Plug Power Inc PLUG. The price target seems to have been set at $26.00 for Plug Power. In the third quarter, Plug Power showed an EPS of $0.30, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $33.62 and a 52-week-low of $12.70. Plug Power closed at $14.11 at the end of the last trading period.

UBS initiated coverage on Bloom Energy Corp BE with a Buy rating. The price target for Bloom Energy is set to $35.00. In the third quarter, Bloom Energy showed an EPS of $0.20, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.47 and a 52-week-low of $11.47. Bloom Energy closed at $21.96 at the end of the last trading period.

With a Buy rating, UBS initiated coverage on Bunge Ltd BG. The price target seems to have been set at $133.00 for Bunge. For the third quarter, Bunge had an EPS of $3.45, compared to year-ago quarter EPS of $3.72. The stock has a 52-week-high of $128.40 and a 52-week-low of $80.41. At the end of the last trading period, Bunge closed at $94.47.

With a Neutral rating, UBS initiated coverage on Gevo Inc GEVO. The price target seems to have been set at $2.25 for Gevo. For the third quarter, Gevo had an EPS of $0.19, compared to year-ago quarter EPS of $0.07. At the moment, the stock has a 52-week-high of $5.49 and a 52-week-low of $1.73. Gevo closed at $2.00 at the end of the last trading period.

UBS initiated coverage on FuelCell Energy Inc FCEL with a Neutral rating. The price target for FuelCell Energy is set to $3.85. For the third quarter, FuelCell Energy had an EPS of $0.08, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $7.33 and a 52-week-low of $2.77. FuelCell Energy closed at $3.65 at the end of the last trading period.

UBS initiated coverage on Vertex Energy Inc VTNR with a Neutral rating. The price target for Vertex Energy is set to $6.90. In the third quarter, Vertex Energy showed an EPS of $0.28, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.10 and a 52-week-low of $3.30. Vertex Energy closed at $6.54 at the end of the last trading period.

UBS initiated coverage on Montauk Renewables Inc MNTK with a Sell rating. The price target for Montauk Renewables is set to $9.00. In the third quarter, Montauk Renewables showed an EPS of $0.08, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $20.78 and a 52-week-low of $9.10. At the end of the last trading period, Montauk Renewables closed at $12.01.

UBS initiated coverage on Aemetis Inc AMTX with a Neutral rating. The price target for Aemetis is set to $4.25. For the third quarter, Aemetis had an EPS of $0.46, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $16.97 and a 52-week-low of $3.71. At the end of the last trading period, Aemetis closed at $4.43.

UBS initiated coverage on Green Plains Inc GPRE with a Buy rating. The price target for Green Plains is set to $45.00. For the third quarter, Green Plains had an EPS of $1.27, compared to year-ago quarter EPS of $1.18. At the moment, the stock has a 52-week-high of $41.25 and a 52-week-low of $26.09. Green Plains closed at $31.25 at the end of the last trading period.

With a Buy rating, UBS initiated coverage on Archer-Daniels Midland Co ADM. The price target seems to have been set at $115.00 for Archer-Daniels Midland. In the third quarter, Archer-Daniels Midland showed an EPS of $1.86, compared to $0.97 from the year-ago quarter. The current stock performance of Archer-Daniels Midland shows a 52-week-high of $98.88 and a 52-week-low of $63.04. Moreover, at the end of the last trading period, the closing price was at $93.23.

With a Buy rating, Needham initiated coverage on BellRing Brands Inc BRBR. The price target seems to have been set at $32.00 for BellRing Brands. BellRing Brands earned $0.31 in the fourth quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $28.95 and a 52-week-low of $20.20. At the end of the last trading period, BellRing Brands closed at $25.12.

With a Buy rating, Needham initiated coverage on The Simply Good Foods Co SMPL. The price target seems to have been set at $42.00 for Simply Good Foods. In the fourth quarter, Simply Good Foods showed an EPS of $0.36, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $45.77 and a 52-week-low of $29.21. Simply Good Foods closed at $37.79 at the end of the last trading period.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...